Herpetic infections of the skin and adjacent mucous membranes can be diagnosed by clinical features in most cases. In patients with an inconclusive clinical diagnosis, in whom herpetic infection is suspected, confirmation by laboratory tests will be necessary.'
suspected or included in the differential diagnosis, the results of cytodiagnosis of herpetic infection (Tzanck smear) were compared with virus culture. Cervical lesions were excluded from this study.
HSV infection was proved by culture in 78 patients and was absent or non-active in 41 patients. Excluded from this study were seven patients who did not yield the virus on culture but had positive Tzanck smear results from three investigators. The characteristic cytopathic effect of herpetic infection was found in 78 patients who yielded HSV on culture. Tzanck smear sensitivity for skin lesions was 79% and for mucous membrane lesions was 81% in men and 52% in women. Tzanck smear specificity for the 41 patients without herpetic infection proved by virus culture was 93%. Differences in sensitivity and specificity between the results found by three investigators (double blind screening) were not significant. The Tzanck smear is reliable, inexpensive, and easy and quick to perform; it is suitable for office diagnosis because it does not require a specialised laboratory.
Herpetic infections of the skin and adjacent mucous membranes can be diagnosed by clinical features in most cases. In patients with an inconclusive clinical diagnosis, in whom herpetic infection is suspected, confirmation by laboratory tests will be necessary.'
Virus culture remains the standard method, but direct and quick confirmation of these herpetic infections can be obtained by the Tzanck smear.
In previous studies, we reported our experience with a cytopathological test based on the Tzanck smear in diagnosing herpetic and non-herpetic vesicular and bullous skin disorders in paediatric practice and in varicella-zoster virus infections (Folkers E The 46 skin lesions were found on the penis (30),_ scrotum (1), vulva (1), perineum (.2), anorectal region (5), buttocks (2), pubic region (3), and groins (2). In men, Tzanck smears were taken from mucous mem-9 brane lesions on the glans penis, coronal sulcus, or sub-preputial sac (35), and from the anorectal mucous membrane (6) . In women, Tzanck smears were taken from mucous membrane lesions in the vestibule or Fig 4 Multinucleated epithelial giant cells, one with an vagina (39). More lesions were ulcerous (99) than inclusion body (arrowed) (Diff-Quik stain). 
Discussion
In treating genital herpes, confirmation of the clinical diagnosis of HSV infection is desirable. Acyclovir, the preferred drug for antiviral treatment, is more effective the earlier it is given.9 As swift diagnosis can therefore 12 Direct and rapid confirmation of herpetic infection, though not specific for HSV 1, HSV 2, or varicellazoster virus, is possible with the Tzanck smear, using rapid staining techniques.5 '3 Our previous study, which was conducted in a paediatric clinic and focused on herpetic and non-herpetic vesicular and bullous skin disorders, indicated the high sensitivity (80%) and specificity (90%) of the Tzanck smear. The Tzanck smear as a diagnostic tool can reliably support a clinical diagnosis of herpetic skin infections.C linicians can easily obtain experience in using the Tzanck smear effectively in office practice with the help of supplemental screening by a cytopathologist or cytotechnologist. We do not consider routine Tzanck smear examination to be suitable for office diagnosis of cervical lesions, because examining cervical smears is complex, takes time, and demands cytopathological experience. Cervical lesions were therefore excluded from this study. Nevertheless a positive Tzanck smear of cervical specimens can support the diagnosis of HSV infection.
The two most important factors in obtaining positive Tzanck smear results were the stage of the infection at the time of sampling and the location of the lesion. Moseley et al reported a Tzanck smear sensitivity of 38% in genital herpes.'4 Our study, however, indicated a higher sensitivity of the Tzanck smear. The Tzanck smear sensitivity in skin lesions of our patients yielding virus on culture was 79%. In vesicular lesions of skin and mucous membranes, the Tzanck smear reached a sensitivity of 81 % in patients with culture proved genital herpes infection. Tzanck smear sensitivity was 80% in men and 44% in women with HSV positive ulcerous mucous membrane lesions. In the total group of patients with culture proved genital herpes the summarised Tzanck smear sensitivity compared with virus culture was 72%.
A discrepancy between a unanimously positive Tzanck smear result and negative culture results was found in seven patients. These can probably be considered as culture failures. These patients were finally assigned a clinical diagnosis of genital herpes, but they were not included in the calculations of this study. As already mentioned, the sensitivity of HSV culture is not 100%, but is presumably more than 90%.
The results showed reduced Tzanck smear sensitivities with differing sites of infection and stages of lesions. The average duration of ulcerous skin lesions was about five days and of ulcerous mucous membrane lesions about four days in men and six days in women.
Viral shedding decreases with the duration of herpetic lesions. A decrease in viral shedding from herpetic lesions of longer duration may correlate with the lower sensitivity of the Tzanck smear. The speed with which cell cultures develop a cytopathological effect (CPE) can be used to estimate roughly the amount of herpes virus antigen present in the lesions investigated. We found no appreciable difference, however, in average time to developing CPE in herpetic mucous membrane lesions between men (7.7 days) and women (7-4 days Positive and negative predictive values depend on the prevalence of the disease in the population investigated. With lower prevalence figures the PV + decreases, but the PV -increases. For example, a prevalence of 50% would give a PV+ of 0.91 and a PV-of0 77, whereas a prevalence of 10% would give a PV + of 0 5 and a PV -of 0.97. In the population attending this STD clinic the prevalence of herpetic infections proved by virus culture of ulcerous genital lesions is about 50%.
The usefulness of a test with a given sensitivity and specificity depends on the purpose it has to be used for. For screening in high risk populations, such as prostitutes, tests with a high sensitivity giving minimum false negative test results are desirable, in which case a high PV -will be obtained. Cytodiagnosis of herpetic infection cannot respond to criteria of a routine screening test excluding herpetic infection; the Tzanck test is therefore not suitable for antenatal screening for HSV infection. On the other hand positive Tzanck smear results are very reliable in confirming the clinical diagnosis of herpetic infection.
In cytodiagnosis PV + and PV -values depend on the skill and experience of the observer. Application of the Tzanck smear routinely in herpetic infections has the advantage of helping observers to gain and maintain experience with cytodiagnosis, so that they can rely on observation and interpretation of the test in cases with inconclusive clinical diagnosis. A positive Tzanck smear result in patients with equivocal clinical features may even obviate the need for virus culture, thus saving cost.
Immunofluorescence cytology using monoclonal antibodies potentially increases the specificity and sensitivity ofcytological preparations, but this method is time consuming and therefore not particularly suitable for office diagnosis.49 Further investigation of this technique is required.
This study, conducted in an STD clinic, shows Tzanck smear results of comparable sensitivity and specificity to those of our previous investigation' (with the exception of the results ofTzanck smear sensitivity obtained in women with ulcerous mucous membrane lesions). Our results show highly reliable positive Tzanck smear results in venereological practice. Moreover this test is inexpensive, quick, and easy to perform, which makes it suitable for office diagnosis.
In dermatological and venereological practice, a positive Tzanck smear result can lead to rapid confirmation of the diagnosis of herpetic infection, prompt treatment with acyclovir, if necessary, and greater assurance of the drug's therapeutic effect. Confirmation of clinically diagnosed herpetic infection is possible with the Tzanck smear, even when virus culture fails.
